KPIs & Operating Metrics(New)
Growth Metrics

Davita (DVA) Cash & Equivalents (2016 - 2025)

Davita (DVA) has disclosed Cash & Equivalents for 17 consecutive years, with $676.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 14.91% to $676.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $676.4 million, a 14.91% decrease, with the full-year FY2025 number at $676.4 million, down 14.91% from a year prior.
  • Cash & Equivalents was $676.4 million for Q4 2025 at Davita, down from $706.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q3 2024 to a low of $244.1 million in Q4 2022.
  • A 5-year average of $563.4 million and a median of $444.1 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 74.84% in 2022, then surged 138.24% in 2024.
  • Davita's Cash & Equivalents stood at $461.9 million in 2021, then tumbled by 47.16% to $244.1 million in 2022, then skyrocketed by 55.71% to $380.1 million in 2023, then skyrocketed by 109.16% to $794.9 million in 2024, then dropped by 14.91% to $676.4 million in 2025.
  • Per Business Quant, the three most recent readings for DVA's Cash & Equivalents are $676.4 million (Q4 2025), $706.0 million (Q3 2025), and $708.4 million (Q2 2025).